Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1989 Apr;33(4):580–582. doi: 10.1128/aac.33.4.580

Antimicrobial susceptibilities of Streptococcus species that cause septicemia in neutropenic patients.

M Venditti 1, P Baiocchi 1, C Santini 1, C Brandimarte 1, P Serra 1, G Gentile 1, C Girmenia 1, P Martino 1
PMCID: PMC172484  PMID: 2729950

Abstract

Sixty-three consecutive streptococcal blood isolates from neutropenic patients, represented mainly by viridans group streptococci, were evaluated in vitro for antibiotic susceptibility. Of these isolates, 79.3% were highly susceptible to penicillin (MIC, less than or equal to 0.12 microgram/ml). Overall, imipenem was the most active agent, followed by teicoplanin and vancomycin. All other agents showed decreased activity against streptococcal isolates that were not highly susceptible to penicillin.

Full text

PDF
581

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bourgault A. M., Wilson W. R., Washington J. A., 2nd Antimicrobial susceptibilities of species of viridans streptococci. J Infect Dis. 1979 Sep;140(3):316–321. doi: 10.1093/infdis/140.3.316. [DOI] [PubMed] [Google Scholar]
  2. Brown A. E. Neutropenia, fever, and infection. Am J Med. 1984 Mar;76(3):421–428. doi: 10.1016/0002-9343(84)90661-2. [DOI] [PubMed] [Google Scholar]
  3. Cohen J., Donnelly J. P., Worsley A. M., Catovsky D., Goldman J. M., Galton D. A. Septicaemia caused by viridans streptococci in neutropenic patients with leukaemia. Lancet. 1983 Dec 24;2(8365-66):1452–1454. doi: 10.1016/s0140-6736(83)90799-7. [DOI] [PubMed] [Google Scholar]
  4. Facklam R. R., Rhoden D. L., Smith P. B. Evaluation of the Rapid Strep system for the identification of clinical isolates of Streptococcus species. J Clin Microbiol. 1984 Nov;20(5):894–898. doi: 10.1128/jcm.20.5.894-898.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Henslee J., Bostrom B., Weisdorf D., Ramsay N., McGlave P., Kersey J. Streptococcal sepsis in bone marrow transplant patients. Lancet. 1984 Feb 18;1(8373):393–393. doi: 10.1016/s0140-6736(84)90440-9. [DOI] [PubMed] [Google Scholar]
  6. Kern W., Kurrle E., Vanek E. High risk of streptococcal septicemia after high dose cytosine arabinoside treatment for acute myelogenous leukemia. Klin Wochenschr. 1987 Aug 17;65(16):773–780. doi: 10.1007/BF01743253. [DOI] [PubMed] [Google Scholar]
  7. Menichetti F., Del Favero A., Guerciolini R., Tonato M., Frongillo R. F., Roila F., Pauluzzi S. Viridans streptococci septicemia in cancer patients: a clinical study. Eur J Epidemiol. 1987 Sep;3(3):316–318. doi: 10.1007/BF00149743. [DOI] [PubMed] [Google Scholar]
  8. Ognibene F. P., Martin S. E., Parker M. M., Schlesinger T., Roach P., Burch C., Shelhamer J. H., Parrillo J. E. Adult respiratory distress syndrome in patients with severe neutropenia. N Engl J Med. 1986 Aug 28;315(9):547–551. doi: 10.1056/NEJM198608283150904. [DOI] [PubMed] [Google Scholar]
  9. Sands M., Sommers H. M., Rubin M. B. Speciation of the "viridans" streptococci. Am J Clin Pathol. 1982 Jul;78(1):78–80. doi: 10.1093/ajcp/78.1.78. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES